|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
ATE159548T1
(de)
|
1990-11-13 |
1997-11-15 |
Immunex Corp |
Bifunktionelle wählbare fusionsgene
|
|
US5197985A
(en)
|
1990-11-16 |
1993-03-30 |
Caplan Arnold I |
Method for enhancing the implantation and differentiation of marrow-derived mesenchymal cells
|
|
EP0804590A1
(en)
|
1993-05-21 |
1997-11-05 |
Targeted Genetics Corporation |
Bifunctional selectable fusion genes based on the cytosine deaminase (cd) gene
|
|
US20020031803A1
(en)
*
|
1997-06-20 |
2002-03-14 |
Cooper Mark J. |
Expression system for production of therapeutic proteins
|
|
US5602301A
(en)
|
1993-11-16 |
1997-02-11 |
Indiana University Foundation |
Non-human mammal having a graft and methods of delivering protein to myocardial tissue
|
|
CA2188575A1
(en)
|
1995-02-28 |
1996-09-06 |
H. Kirk Hammond |
Gene transfer-mediated angiogenesis therapy
|
|
US6121246A
(en)
|
1995-10-20 |
2000-09-19 |
St. Elizabeth's Medical Center Of Boston, Inc. |
Method for treating ischemic tissue
|
|
US5980887A
(en)
|
1996-11-08 |
1999-11-09 |
St. Elizabeth's Medical Center Of Boston |
Methods for enhancing angiogenesis with endothelial progenitor cells
|
|
NZ336838A
(en)
*
|
1997-01-29 |
2002-04-26 |
Cornell Res Foundation Inc |
A method of enhancing the level of perfusion of blood to a target tissue by administering an adenoviral vector encoded with an angiogenic peptide within 0.5-15 cm3 of the tissue
|
|
EP0998486B2
(en)
|
1997-06-13 |
2012-02-01 |
Genentech, Inc. |
Protein recovery by chromatography followed by filtration upon a charged layer
|
|
MXPA00003885A
(es)
|
1997-10-22 |
2004-04-23 |
Inst Genetics Llc |
Quimiocinas con modificiaciones de la terminacion amino.
|
|
US20030129750A1
(en)
*
|
1998-02-05 |
2003-07-10 |
Yitzhack Schwartz |
Homing of donor cells to a target zone in tissue using active therapeutics or substances
|
|
JP2002502608A
(ja)
|
1998-02-06 |
2002-01-29 |
コラテラル・セラピューティックス・インコーポレイテッド |
血管新生促進因子である血管内皮細胞成長因子：ｖｅｇｆの変異体
|
|
US6676937B1
(en)
|
1998-03-09 |
2004-01-13 |
Caritas St. Elizabeth's Medical Center Of Boston Inc. |
Compositions and methods for modulating vascularization
|
|
CA2322559C
(en)
|
1998-03-09 |
2012-07-17 |
St. Elizabeth's Medical Center |
Compositions and methods for modulating vascularization
|
|
WO1999050461A1
(en)
|
1998-03-30 |
1999-10-07 |
Northwest Biotherapeutics, Inc. |
Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis
|
|
US20020107196A1
(en)
|
1998-07-21 |
2002-08-08 |
Smithkline Beecham Corporation |
Method for inducing chemotaxis in endothelial cells by administering stromal cell derived factor-1alpha
|
|
IL125532A0
(en)
|
1998-07-27 |
1999-03-12 |
Yeda Res & Dev |
Hematopoietic cell composition for use in transplantation
|
|
AU5241099A
(en)
|
1998-07-31 |
2000-02-21 |
Trustees Of Columbia University In The City Of New York, The |
Use of inhibitors of the activation of cxcr4 receptor by sdf-1 in treating rheumatoid arthritis
|
|
WO2000015285A1
(en)
*
|
1998-09-14 |
2000-03-23 |
Mirus Corporation |
A process for delivering nucleic acids to cardiac tissue
|
|
DE19844479C1
(de)
|
1998-09-28 |
2000-04-13 |
Siemens Ag |
Integrierter Speicher mit einem differentiellen Leseverstärker
|
|
US7399751B2
(en)
|
1999-11-04 |
2008-07-15 |
Sertoli Technologies, Inc. |
Production of a biological factor and creation of an immunologically privileged environment using genetically altered Sertoli cells
|
|
EP1013770A1
(en)
*
|
1998-12-23 |
2000-06-28 |
Université Louis Pasteur de Strasbourg |
Non-viral transfection vector
|
|
DE19900743A1
(de)
*
|
1999-01-12 |
2000-07-13 |
Aventis Pharma Gmbh |
Neue komplexbildende Proteine
|
|
US6333194B1
(en)
|
1999-01-19 |
2001-12-25 |
The Children's Hospital Of Philadelphia |
Hydrogel compositions for controlled delivery of virus vectors and methods of use thereof
|
|
EP1154780A2
(en)
|
1999-02-26 |
2001-11-21 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Bone marrow transplantation for hepatic regeneration and repair
|
|
US20050153451A1
(en)
*
|
1999-02-26 |
2005-07-14 |
Wolff Jon A. |
Intravascular delivery of non-viral nucleic acid
|
|
EP1041148A1
(en)
|
1999-04-02 |
2000-10-04 |
Mogen International N.V. |
Pathogen inducible promoter
|
|
US6448054B1
(en)
|
1999-04-08 |
2002-09-10 |
The General Hospital Corporation |
Purposeful movement of human migratory cells away from an agent source
|
|
US7125856B1
(en)
|
1999-04-15 |
2006-10-24 |
St. Elizabeth's Medical Center Of Boston, Inc. |
Angiogenic growth factors for treatment of peripheral neuropathy
|
|
US6358697B2
(en)
|
1999-04-21 |
2002-03-19 |
Children's Hospital Medical Center |
Intracellular pharmaceutical targeting
|
|
AU4801501A
(en)
*
|
2000-05-26 |
2001-11-29 |
Transgene S.A. |
Complex for transferring an anionic substance of interest into a cell
|
|
WO2001094420A1
(en)
|
2000-06-05 |
2001-12-13 |
The Trustees Of Columbia University In The City Of New York |
Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury
|
|
AU2001284695A1
(en)
|
2000-07-31 |
2002-02-13 |
New York Medical College |
Methods and compositions for the repair and/or regeneration of damaged myocardium
|
|
CA2386103A1
(en)
*
|
2000-08-04 |
2002-02-14 |
Human Genome Sciences, Inc. |
Vascular endothelial growth factor 2
|
|
US20040009940A1
(en)
*
|
2000-10-20 |
2004-01-15 |
Coleman Michael E. |
Gene delivery formulations and methods for treatment of ischemic conditions
|
|
US7402567B2
(en)
|
2000-10-27 |
2008-07-22 |
The Regents Of The University Of California |
Treatment of disease by inducing cell apoptosis
|
|
WO2002036078A2
(en)
|
2000-11-05 |
2002-05-10 |
University Of Florida |
Targeting pluripotent stem cells to tissues
|
|
US7405076B2
(en)
|
2000-11-14 |
2008-07-29 |
Universite Libre De Bruxelles |
Generation and use of dendritic cells
|
|
AU2002225756A1
(en)
|
2000-12-01 |
2002-06-11 |
Schering Corporation |
Uses of mammalian genes and related reagents
|
|
AR027161A1
(es)
*
|
2001-05-15 |
2003-03-19 |
Bio Sidus S A |
Metodo para inducir la proliferacion neovascular y regeneracion tisular
|
|
US7399740B2
(en)
|
2001-06-28 |
2008-07-15 |
Yeda Research And Development Co. Ltd. |
Poly-Glu,Tyr for neuroprotective therapy
|
|
WO2003014336A1
(en)
|
2001-08-07 |
2003-02-20 |
Kirin Beer Kabushiki Kaisha |
Process for preparing hematopoietic stem cells
|
|
ATE541921T1
(de)
|
2001-09-14 |
2012-02-15 |
Stem Cell Therapeutics Inc |
Prolaktin-induzierte zunahme an neuronalen stammzellen und dessen therapeutische anwendung
|
|
US7402724B2
(en)
|
2002-01-04 |
2008-07-22 |
Mayo Foundation For Medical Education And Research |
Longevity and PAPP-A
|
|
AU2002226683A1
(en)
|
2002-01-17 |
2003-07-30 |
Cardio Incorporated |
Complex therapy for tissue regeneration
|
|
FR2843697B1
(fr)
*
|
2002-08-26 |
2005-12-09 |
Sod Conseils Rech Applic |
L'heterocarpine, une proteine d'origine vegetale aux proprietes anticancereuses
|
|
US7396537B1
(en)
|
2002-02-28 |
2008-07-08 |
The Trustees Of The University Of Pennsylvania |
Cell delivery patch for myocardial tissue engineering
|
|
US7282222B2
(en)
|
2002-03-15 |
2007-10-16 |
The United States Of America As Represented By The Department Of Veterans Affairs |
Methods and compositions for directing cells to target organs
|
|
US20030199464A1
(en)
|
2002-04-23 |
2003-10-23 |
Silviu Itescu |
Regeneration of endogenous myocardial tissue by induction of neovascularization
|
|
US20040037811A1
(en)
*
|
2002-08-22 |
2004-02-26 |
The Cleveland Clinic Foundation |
Stromal cell-derived factor-1 mediates stem cell homing and tissue regeneration in ischemic cardiomyopathy
|
|
US20050271639A1
(en)
|
2002-08-22 |
2005-12-08 |
Penn Marc S |
Genetically engineered cells for therapeutic applications
|
|
US20140170116A9
(en)
|
2002-08-22 |
2014-06-19 |
Marc S. Penn |
Method of treating ischemic disorders
|
|
US20040161412A1
(en)
*
|
2002-08-22 |
2004-08-19 |
The Cleveland Clinic Foundation |
Cell-based VEGF delivery
|
|
JP2004099471A
(ja)
|
2002-09-05 |
2004-04-02 |
Cardio Corp |
心筋梗塞および心不全の治療薬
|
|
AU2003300332A1
(en)
|
2002-10-08 |
2004-05-04 |
American National Red Cross |
Method for enriching adherent monocyte populations
|
|
WO2004044142A2
(en)
|
2002-11-05 |
2004-05-27 |
The Brigham And Women's Hospital, Inc. |
Mesenchymal stem cells and methods of use thereof
|
|
US20040258670A1
(en)
|
2002-12-05 |
2004-12-23 |
Case Western Reserve University |
Cell-based therapies for ischemia
|
|
US20070036756A1
(en)
*
|
2003-02-19 |
2007-02-15 |
Dnavec Research, Inc. |
Method for treating ischemic diseases
|
|
AU2003902037A0
(en)
|
2003-04-24 |
2003-05-15 |
Mclachlan, Craig |
Method for tissue growth
|
|
US20050104072A1
(en)
|
2003-08-14 |
2005-05-19 |
Slater David B.Jr. |
Localized annealing of metal-silicon carbide ohmic contacts and devices so formed
|
|
US7396680B2
(en)
|
2003-10-31 |
2008-07-08 |
Cornell Research Foundation, Inc. |
Stem cell-specific promoters and their use
|
|
IL158868A0
(en)
|
2003-11-13 |
2004-05-12 |
Yeda Res & Dev |
Methods of generating and using stem cells enriched with immature primitive progenitor
|
|
US8071364B2
(en)
*
|
2003-12-24 |
2011-12-06 |
Transgenrx, Inc. |
Gene therapy using transposon-based vectors
|
|
JP5269411B2
(ja)
|
2004-06-21 |
2013-08-21 |
ザ クリーブランド クリニック ファウンデーション |
幹細胞をホーミングさせるためのｃｃｒリガンド
|
|
EP1803464A4
(en)
|
2004-09-17 |
2009-09-09 |
Cellgentech Inc |
TOPICAL PREPARATION FOR THE TREATMENT OF SKIN DISEASES
|
|
CA2581652C
(en)
*
|
2004-09-27 |
2013-10-29 |
Valentis, Inc. |
Formulations and methods for treatment of inflammatory diseases
|
|
US20060105950A1
(en)
|
2004-10-25 |
2006-05-18 |
Caritas St. Elizabeth's Medical Center Of Boston, Inc. |
Morphogen compositions and use thereof to treat wounds
|
|
WO2006083394A2
(en)
|
2004-12-21 |
2006-08-10 |
Ethicon, Inc. |
Postpartum cells derived from placental tissue, and methods of making, culturing, and using the same
|
|
US7951632B1
(en)
|
2005-01-26 |
2011-05-31 |
University Of Central Florida |
Optical device and method of making
|
|
GB2424312B
(en)
|
2005-03-14 |
2010-03-03 |
Denso Corp |
Method of forming an ohmic contact in wide band semiconductor
|
|
EP2546865B1
(en)
|
2005-09-16 |
2023-12-06 |
Wolfspeed, Inc. |
Methods of processing semiconductor wafers having silicon carbide power devices thereon
|
|
US8664664B2
(en)
|
2006-01-10 |
2014-03-04 |
Cree, Inc. |
Silicon carbide dimpled substrate
|
|
US20070173471A1
(en)
|
2006-01-24 |
2007-07-26 |
Losordo Douglas W |
Morphogen compositions and methods of use thereof to treat heart disorders
|
|
US7405195B2
(en)
|
2006-03-27 |
2008-07-29 |
Natural Beauty Bio-Technology Limited |
Cosmetic compositions
|
|
WO2009079451A2
(en)
|
2007-12-14 |
2009-06-25 |
The Cleveland Clinic Foundation |
Compositions and methods of promoting wound healing
|
|
AU2010286511B2
(en)
|
2009-08-28 |
2016-05-26 |
Juventas Therapeutics, Inc. |
SDF-1 delivery for treating ischemic tissue
|
|
WO2012037083A2
(en)
|
2010-09-15 |
2012-03-22 |
The Cleveland Clinic Foundation |
Compositions and method for promoting musculoskeletal repair
|
|
US20120068161A1
(en)
|
2010-09-16 |
2012-03-22 |
Lee Keon-Jae |
Method for forming graphene using laser beam, graphene semiconductor manufactured by the same, and graphene transistor having graphene semiconductor
|
|
JP5569376B2
(ja)
|
2010-12-07 |
2014-08-13 |
住友電気工業株式会社 |
半導体装置の製造方法
|